Related Experiment Video
Updated: Jun 20, 2026

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients
Tajinder P Singh1, Leah B Edwards, Richard Kirk
1Department of Cardiology, Children's Hospital Boston, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. tp.singh@cardio.chboston.org
Insights
Pediatric heart transplant survival has improved over time, even with sicker patients. This improvement is mainly due to better outcomes in the first six months post-transplant.
Area of Science:
- Pediatric Cardiology
- Transplant Surgery
- Immunology
Background:
- Pediatric heart transplant (HT) survival has improved in recent years.
- Previous studies have not fully assessed the impact of transplant era on survival after accounting for baseline risk factors.
Purpose of the Study:
- To evaluate the risk-adjusted effect of transplant era on 5-year survival in pediatric heart transplant recipients.
- To identify factors influencing conditional 5-year survival post-transplant.
Main Methods:
- Compared baseline characteristics and 5-year survival in 3,376 pediatric HT recipients across three eras (early, middle, recent).
- Utilized a Cox proportional hazards model to determine risk-adjusted era effects on death or graft loss (retransplant).
Main Results:
- Recent era recipients had a higher incidence of retransplants and pre-formed antibodies, and were more likely to require mechanical support at transplant.
- Risk-adjusted 5-year survival was significantly better in the middle and recent eras compared to the early era.
- Factors influencing conditional 5-year survival included recipient/donor age, gender, retransplant status, pre-formed antibodies, and inotrope use, but not the transplant era itself.
Conclusions:
- Risk-adjusted survival in pediatric heart transplant recipients has improved over time, despite an increasing baseline risk profile.
- The observed era effect on survival is primarily attributed to enhanced outcomes within the first six months post-transplant.
Background:
Post-transplant survival in pediatric heart transplant (HT) recipients has improved for recent era recipients. However, the era effect has not been assessed after adjusting for baseline risk factors in HT recipients.
Methods:
We compared baseline characteristics and 5-year survival in pediatric HT recipients in three eras (early: July 1994 to June 1997, n = 1,153; middle: July 1997 to June 2000, n = 1,085; recent: July 2000 to June 2003, n = 1,138) for all recipients <18 years of age who were reported to the registry of the International Society for Heart and Lung Transplantation (n = 3,376). We used a Cox proportional hazards model for determining risk-adjusted era effect on death or graft loss (retransplant).
Results:
There were more retransplants and more recipients had pre-formed antibodies in the recent eras. Recent era recipients were more likely to be supported by inotropes, ventilator, mechanical support and dialysis at the time of transplant. Five-year survival was better for patients who underwent HT in the middle era (hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.68 to 0.93, p = 0.003) and the recent era (HR 0.70, CI 0.60 to 0.82, p < 0.001) as compared with those in the early era, adjusted for baseline risk factors. The determinants of conditional 5-year survival in HT recipients who survived the first 6 months were recipient and donor age, recipient gender, retransplant, pre-formed antibodies and inotropes, but not transplant era.
Conclusions:
Despite the worse baseline risk profile of pediatric HT recipients in recent years, their risk-adjusted survival during the first 5 years after transplant has improved. The entire era effect appears to be due to improved survival during the first 6 months post-transplant.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management